Developments in diagnostics and treatment for myeloma
Charlotte Bloodworth Haematology clinical nurse specialist, University Hospital of Wales, Cardiff and Vale University Health Board
Marcia Short Haematology staff nurse, University Hospital of Wales, Cardiff and Vale University Health Board
Charlotte Bloodworth and Marcia Short describe how nurses can use these advances to improve support for people living with the disease
Over the past decade, many novel treatments for myeloma have been developed and are now in use. The limited treatments delivered previously were chemotherapy based and either intensive, such as the autologous transplant, or gentle oral drugs, such as low-dose melphalan and dexamethasone. In addition to treatment developments, diagnostics have also evolved.
This article explores three important aspects of modern myeloma care: diagnostics, treatments and survivorship. It discusses how nurses can improve their input in each area to provide more effective support for people living longer with the disease.
Cancer Nursing Practice. 14, 3, 33-37. doi: 10.7748/cnp.14.3.33.e1172Correspondence
This article has been subject to double blind peer reviewConflict of interest
Received: 23 December 2014
Accepted: 16 February 2015